Li Ding

11.6k total citations · 1 hit paper
166 papers, 4.8k citations indexed

About

Li Ding is a scholar working on Molecular Biology, Epidemiology and Biomedical Engineering. According to data from OpenAlex, Li Ding has authored 166 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 37 papers in Epidemiology and 31 papers in Biomedical Engineering. Recurrent topics in Li Ding's work include Nanoplatforms for cancer theranostics (25 papers), Extracellular vesicles in disease (17 papers) and Mycobacterium research and diagnosis (13 papers). Li Ding is often cited by papers focused on Nanoplatforms for cancer theranostics (25 papers), Extracellular vesicles in disease (17 papers) and Mycobacterium research and diagnosis (13 papers). Li Ding collaborates with scholars based in China, United States and Brazil. Li Ding's co-authors include Steven M. Holland, Yu Chen, Wei Feng, Caihong Dong, Meiqi Chang, Wen Shi, Yinghong Wang, Jianlin Shi, Hui Huang and Luodan Yu and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Li Ding

157 papers receiving 4.7k citations

Hit Papers

Structural characterization and combined immunomodulatory... 2025 2026 2025 5 10 15 20

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Ding China 42 1.4k 1.1k 990 963 727 166 4.8k
Ting Pan China 42 2.4k 1.7× 525 0.5× 470 0.5× 956 1.0× 586 0.8× 260 5.9k
Cristina Rodrı́guez-Padilla Mexico 31 1.7k 1.2× 593 0.5× 355 0.4× 733 0.8× 403 0.6× 206 4.8k
Horacio Bach Canada 37 2.0k 1.4× 1.5k 1.3× 797 0.8× 401 0.4× 937 1.3× 134 6.9k
Monica Neagu Romania 38 1.4k 1.0× 546 0.5× 553 0.6× 808 0.8× 204 0.3× 186 4.6k
Feng Qian China 47 2.7k 1.9× 1.1k 1.0× 657 0.7× 4.0k 4.1× 1.0k 1.4× 148 10.0k
Xian Qi China 46 2.5k 1.7× 1.4k 1.2× 849 0.9× 642 0.7× 1.4k 2.0× 205 6.2k
Ligong Lu China 44 2.2k 1.5× 1.4k 1.3× 553 0.6× 834 0.9× 315 0.4× 226 6.4k
Hua Zhu China 42 2.5k 1.7× 696 0.6× 634 0.6× 345 0.4× 354 0.5× 311 7.1k
Hagen von Briesen Germany 43 2.1k 1.4× 1.1k 1.0× 466 0.5× 699 0.7× 1.2k 1.7× 126 6.4k
Xizhong Shen China 47 3.9k 2.7× 923 0.8× 1.0k 1.1× 499 0.5× 207 0.3× 181 6.7k

Countries citing papers authored by Li Ding

Since Specialization
Citations

This map shows the geographic impact of Li Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ding more than expected).

Fields of papers citing papers by Li Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ding. The network helps show where Li Ding may publish in the future.

Co-authorship network of co-authors of Li Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Li Ding. A scholar is included among the top collaborators of Li Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Ding. Li Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zeyu, Xue Wang, Xinran Song, et al.. (2025). 2D Indium‐Vacancy‐Rich ZnIn2S4 Nanocatalysts for Sonocatalytic Cancer Suppression by Boosting Cancer‐Cell Pyroptosis. Advanced Materials. 37(24). e2414432–e2414432. 1 indexed citations
2.
Ding, Li, Qi Song, Tiantian Liu, Youdi Yang, & Qiang Li. (2025). Se-doping activated NiCo oxyhydroxides catalyst for highly selective electrochemical oxidation of biomass-derived aldehydes to high value-added carboxylic acids. Chemical Engineering Science. 321. 122842–122842.
3.
Ding, Li, Guanlin Wang, Jieliang Wang, et al.. (2024). Targeted treatment for biofilm-based infections using PEGylated tobramycin. Journal of Controlled Release. 372. 43–58. 5 indexed citations
4.
Song, Xinran, Pan Li, Li Ding, et al.. (2024). Two‐Dimensional Atomically Thin Piezoelectric Nanosheets for Efficient Pyroptosis‐Dominated Sonopiezoelectric Cancer Therapy. Advanced Science. 11(42). e2405741–e2405741. 6 indexed citations
5.
Ding, Li, et al.. (2023). Mortality following mechanical thrombectomy for ischemic stroke in patients with COVID-19. Journal of Stroke and Cerebrovascular Diseases. 32(8). 107171–107171. 3 indexed citations
6.
Lin, Michelle, et al.. (2023). The effect of COVID-19 on treatment and outcomes following ischemic stroke: A national assessment. Clinical Neurology and Neurosurgery. 233. 107982–107982.
8.
Han, Jing, Tao Meng, Xuan Wu, et al.. (2021). Reporting quality of practice guidelines on colorectal cancer: evaluation using the RIGHT reporting checklist. Annals of Translational Medicine. 9(14). 1175–1175. 3 indexed citations
10.
Zhu, Xianbing, Xiaoyuan Ji, Na Kong, et al.. (2018). Intracellular Mechanistic Understanding of 2D MoS2 Nanosheets for Anti-Exocytosis-Enhanced Synergistic Cancer Therapy. ACS Nano. 12(3). 2922–2938. 194 indexed citations
11.
Ding, Li, Khim Yong Goh, & Cheng Suang Heng. (2017). Price Competition and Demand for Online Content: Uncovering the Role of Content Differentiation and Network Structure. Journal of the Association for Information Systems. 1 indexed citations
12.
Ding, Li, Xianbing Zhu, Yiling Wang, et al.. (2017). Intracellular Fate of Nanoparticles with Polydopamine Surface Engineering and a Novel Strategy for Exocytosis-Inhibiting, Lysosome Impairment-Based Cancer Therapy. Nano Letters. 17(11). 6790–6801. 151 indexed citations
13.
Sampaio, Elizabeth P., Li Ding, Stacey Rose, et al.. (2017). Novel signal transducer and activator of transcription 1 mutation disrupts small ubiquitin-related modifier conjugation causing gain of function. Journal of Allergy and Clinical Immunology. 141(5). 1844–1853.e2. 17 indexed citations
14.
Zhang, Minjie, Ping Zhu, Li Ding, & Ping Chen. (2016). Identification of isorhmnetin and chlorogenic acid and determination of total flavonoids in apple pollen. 36(4). 623. 1 indexed citations
15.
Greenberg, David E., Adam R. Shoffner, Kimberly R. Marshall‐Batty, et al.. (2012). Serologic Reactivity to the Emerging Pathogen Granulibacter bethesdensis. The Journal of Infectious Diseases. 206(6). 943–951. 5 indexed citations
16.
Wu, Xinhua, Li Ding, Zhonghai Li, et al.. (2010). [Determination of the migration of bisphenol diglycidyl ethers from food contact materials by high performance chromatography-tandem mass spectrometry coupled with multi-walled carbon nanotubes solid phase extraction].. PubMed. 28(11). 1094–8. 2 indexed citations
17.
Gozalo, Alfonso S., Victoria Hoffmann, Lauren Brinster, et al.. (2010). Spontaneous Staphylococcus xylosus infection in mice deficient in NADPH oxidase and comparison with other laboratory mouse strains.. PubMed Central. 42 indexed citations
18.
Greenberg, David E., Li Ding, Adrian M. Zelazny, et al.. (2006). A Novel Bacterium Associated with Lymphadenitis in a Patient with Chronic Granulomatous Disease. PLoS Pathogens. 2(4). e28–e28. 55 indexed citations
19.
Patel, Smita Y., Li Ding, Margaret R. Brown, et al.. (2005). Anti-IFN-γ Autoantibodies in Disseminated Nontuberculous Mycobacterial Infections. The Journal of Immunology. 175(7). 4769–4776. 152 indexed citations
20.
Ding, Li. (2004). Alkaloids from Zanthoxylum nitidum. Chinese Journal of Natural Medicines. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026